[1]邢诗安.叶酸受体及其在肿瘤核医学中的应用[J].国际放射医学核医学杂志,2002,26(6):257-259.
　XING Shi-an.Folate receptor and the application in tumor nuclear medicine[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(6):257-259.
点击复制

叶酸受体及其在肿瘤核医学中的应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
26
期数:
2002年第6期
页码:
257-259
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Folate receptor and the application in tumor nuclear medicine
作者:
邢诗安
430022 武汉, 华中科技大学同济医学院附属协和医院核医学科
Author(s):
XING Shi-an
Department of Nuclear Medicine, Union Hospital, Tongji medical college, Huazhong University of Science and Technology, Wuhan 430022, China
关键词:
肿瘤; 叶酸; 受体显像
Keywords:
tumor; folate receptor; receptor imaging
分类号:
R817.4
摘要:
叶酸受体是一种在肿瘤细胞膜表面高度表达的蛋白膜受体,有α和β两种亚型。来源于上皮组织的癌组织高度表达α亚型受体,非上皮来源的癌组织主要表达β亚型受体,两种亚型受体对叶酸及其类似物都有很高的亲和力。叶酸受体在几乎所有的卵巢癌和大部分的恶性肿瘤如乳腺癌、宫颈癌、结肠癌、直肠癌、鼻咽癌等中都有表达,同时在正常组织的表达又高度保守。通过对其分类、结构、染色体定位、分布、配体及其在肿瘤核医学中应用的研究,将有助于肿瘤的早期诊断和针对肿瘤细胞的靶向性治疗。
Abstract:
The folate receptor is a membrane protein overexpressed in tumor cells.Two folate receptor isoforms have been identified in humans by the modern molecular biology, α and β.The type α receptor is frequently overexpressed in epithelial-lineaged tumors and the type β in nonepithelial-derived tumors.Both isoforms show a high affinity for folic acid.The folate receptor is overexpressed in approximately 100% of other ovarian carcinomas and a wide variety of other human cancers,including breast,cervical,colorectal and nasopharyngeal tumors,while being highly restricted in most normal tissues.The studies of folate receptor in the isoforms,structures,gene mapping,distribution,ligand and application in trmor nuclear medicine will be helpful in the early diagnosis and treatment of tumors.

参考文献/References:

[1] Ratnam M, Marquardt H, Duhring JL, et al. Homologous membrane folate binding proteins in human placenta:cloning and sequence of a cDNA[J]. Biochemistry, 1989, 28(20):8249-8254.
[2] Lacey SW, Sanders JM, Rothberg KG, et al. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol[J]. J Clin Invest, 1989, 84(2):715-720.
[3] Coney LR, Tomassetti A, Carayannopoulos L, et al. Cloning of a tumor-associated antigen:MOv18 and MOv19 antibodies recognize a folate-binding protein[J]. Cancer Res, 1991, 51(22):6125-6132.
[4] Antony AC. The biological chemistry of folate receptors[J]. Blood, 1992, 79(11):2807-2820.
[5] Weitman SD, Weinberg AG, Coney LR, et al. Cellular localization of the folate receptor:potential role in drug toxicity and folate homeostasis[J]. Cancer Res, 1992, 52(23):6708-6711.
[6] Ross JF, Chaudhuri PK, Ratnam M. Diffierential regulation of folate receptor isoforms in normal malignant tissues in vivo and in established cell lines[J]. Cancer, 1994, 73:2432-2443.
[7] Wang X, Shen F, Freisheim JH, et al. Differential stereospicifities and affinity of folate receptor isoforms for folate compounds and antifolates[J]. Biochem Pharmacol, 1992, 44:1898-1901.
[8] Visser GW, Klok RP, Gebbinck JW, et al. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN[J]. J Nucl Med, 2001, 42(3):509-519.
[9] Casalini P, Luison E, Menard S, et al. Tumor pretargeting:role of avidin/streptavidin on monoclonal antibody internalization[J]. J Nucl Med, 1997, 38(9):1378-1381.
[10] Crippa F, Bolis G, Seregni E, et al. Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18:clinical results in patients with minimal residual disease of ovarian cancer[J]. Eur J Cancer, 1995, 31A(5):686-690.
[11] Leamon CP, Low PS. Delivery of macromolecules into living cells:a method that exploits folate receptor endocytosis[J]. Proc Natl Acad Sci USA, 1991, 88(13):5572-5576.
[12] Mathias CJ, Wang S, Lee RJ, et al. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate[J]. J Nucl Med, 1996, 37(6):1003-1008.
[13] Mathias CJ, Wang S, Waters DJ, et al. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical[J]. J Nucl Med, 1998, 39(9):1579-1585.
[14] Mathias CJ, Hubers D, Low PS, et al. Synthesis of 99Tcm-DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical[J]. Bioconjug Chem, 2000, 11(2):253-257.
[15] Guo W, Hinkle GH, Lee RJ. 99Tcm-HYNIC-folate:a novel receptor-based targeted radiopharmaceutical for tumor imaging[J]. J Nucl Med, 1999, 40(9):1563-1569.
[16] Wang S, Lee RJ, Cauchon G, et al. Delivery of antisense oligodeoxynucleotides against the human epidermal growth factor receptor into cultured KB cell with liposome conjugated to folate via polyethylene glycol[J]. Proc Natl Acad Sci USA, 1995, 92:3312-3318.
[17] Ni S, Stephenson SM, Lee RJ. Folate receptor targeted delivery of liposomal daunorubicin into tumor cells[J]. Anticancer Res, 2002, 22(4):2131-2135.

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
　He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
　Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
　Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
　Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
　zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
　Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
　Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
　Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
　Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[10]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
　Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]

备注/Memo

备注/Memo:
收稿日期:2001-12-03。
作者简介:邢诗安(19795-),女,湖南浏阳人,硕士研究生,主要从事肿瘤核医学方面的工作。
更新日期/Last Update: 1900-01-01